Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1957 Jul 1;106(1):159–177. doi: 10.1084/jem.106.1.159

INFECTION INDUCED BY ORAL ADMINISTRATION OF ATTENUATED POLIOVIRUS TO PERSONS POSSESSING HOMOTYPIC ANTIBODY

Dorothy M Horstmann 1, J R Paul 1, J L Melnick 1, Joyce V Deutsch 1
PMCID: PMC2136730  PMID: 13439122

Abstract

Four of five individuals possessing homotypic antibody in titers of 8 to 64 were infected on being fed Type III (Leon KP-34) poliovirus attenuated by Sabin by passage through tissue culture. None of the infected subjects or controls showed any evidence of illness which could be attributed to virus infection. There was no evidence of spread of infection to any of the control adult wardmates of the experimental subjects, although the two groups were in close contact: none of the controls excreted virus, none showed any antibody shift. One control who had no Type III antibodies at the start of the experiment was still antibody-negative on the 63rd day of the experiment. Three of the four individuals who became infected had naturally acquired-Type III antibodies; the other had antibodies induced by formalinized vaccine. Virus excretion in the stool was of short duration (7 to 13 days) in the three with natural antibodies, and lasted at least 6 weeks after feeding in the vaccinated child. Virus in the throat was detected only in the two persons receiving the larger virus dose (107.5 TCD50). In them it was present in small amounts between the 2nd and 6th day after feeding. No virus was detected in the blood of any of the infected individuals. The antibody responses of the four infected individuals were variable. There was no clear correlation with virus dosage, amount of virus excretion in the stools, or presence of virus in the throat. Only the child whose neutralizing antibodies were "Salk" vaccine induced showed a marked CF response. The virus excreted by two of the individuals who became infected, as tested in the 2nd tissue culture passage by monkey inoculation, was slightly more neurotropic than the virus which was ingested. Virus excreted by one of these individuals behaved as a virulent strain when tested by the in vitro plaque virulence test, while that isolated from the other had the characteristics of an attenuated strain in this test.

Full Text

The Full Text of this article is available as a PDF (899.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK F. L., MELNICK J. L. The specificity of the complement fixation test in poliomyelitis. Yale J Biol Med. 1954 Apr;26(5):385–393. [PMC free article] [PubMed] [Google Scholar]
  2. CONNOLLY J. H., DANE D. S., DICK G. W., FISHER O. D., MCKEOWN F. Vaccination against poliomyelitis with live virus vaccines. I. A trial of TN type II vaccine. Br Med J. 1957 Jan 12;1(5010):59–65. [PubMed] [Google Scholar]
  3. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FLACK A., HUMMELER K., HUNT A. D., Jr, JERVIS G. A., KOPROWSKI H., NORTON T. W., STOKES J., Jr Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies. J Am Med Assoc. 1956 Dec 1;162(14):1281–1288. [PubMed] [Google Scholar]
  5. FULTON F., DUMBELL K. R. The serological comparison of strains of influenza virus. J Gen Microbiol. 1949 Jan;3(1):97–111. doi: 10.1099/00221287-3-1-97. [DOI] [PubMed] [Google Scholar]
  6. GELFAND H. M., FOX J. P., LEBLANC D. R. Observations on natural poliovirus infections in immunized children. Am J Public Health Nations Health. 1957 Apr;47(4 Pt 1):421–431. doi: 10.2105/ajph.47.4_pt_1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HORSTMANN D. M., MELNICK J. L. Poliomyelitis in chimpanzees; studies in homologous and heterologous immunity following inapparent infection. J Exp Med. 1950 Jun 1;91(6):573–597. doi: 10.1084/jem.91.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOWE H. A., BODIAN D., MORGAN I. M. Subclinical poliomyelitis in the chimpanzee and its relation to alimentary reinfection. Am J Hyg. 1950 Jan;51(1):85-108, tab. doi: 10.1093/oxfordjournals.aje.a119379. [DOI] [PubMed] [Google Scholar]
  9. HSIUNG G. D., MELNICK J. L. Plaque formation with poliomyelitis, Coxsackie, and orphan (echo) viruses in bottle cultures of monkey epithelial cells. Virology. 1955 Dec;1(5):533–535. doi: 10.1016/0042-6822(55)90041-6. [DOI] [PubMed] [Google Scholar]
  10. Horstmann D. M., Ward R., Melnick J. L. THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. III. PERSISTENCE OF VIRUS IN STOOLS AFTER ACUTE INFECTION. J Clin Invest. 1946 Mar;25(2):278–283. doi: 10.1172/JCI101707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KESSEL J. F., PAIT C. F. Differentiation of three groups of poliomyelitis virus. Proc Soc Exp Biol Med. 1949 Feb;70(2):315–315. doi: 10.3181/00379727-70-16911. [DOI] [PubMed] [Google Scholar]
  12. KOPROWSKI H., JERVIS G. A., NORTON T. W. Administration of an attenuated type I poliomyelitis virus to human subjects. Proc Soc Exp Biol Med. 1954 Jun;86(2):244–247. doi: 10.3181/00379727-86-21062. [DOI] [PubMed] [Google Scholar]
  13. KOPROWSKI H., JERVIS G. A., NORTON T. W. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg. 1952 Jan;55(1):108–124. doi: 10.1093/oxfordjournals.aje.a119499. [DOI] [PubMed] [Google Scholar]
  14. LI C. P., SCHAEFFER M. Isolation of a non-neurotropic variant of type I poliomyelitis virus. Proc Soc Exp Biol Med. 1954 Oct;87(1):148–153. doi: 10.3181/00379727-87-21317. [DOI] [PubMed] [Google Scholar]
  15. MELNICK J. L., OPTON E. M. Assay of poliomyelitis neutralizing antibody in disposable plastic panels. Bull World Health Organ. 1956;14(1):129–146. [PMC free article] [PubMed] [Google Scholar]
  16. MELNICK J. L. Tissue culture techniques and their application to original isolation, growth, and assay of poliomyelitis and orphan viruses. Ann N Y Acad Sci. 1955 Sep 27;61(4):754-72; discussion, 772-3. doi: 10.1111/j.1749-6632.1955.tb42532.x. [DOI] [PubMed] [Google Scholar]
  17. RIORDAN J. T., LEDINKO N., MELNICK J. L. Multiplication of poliomyelitis viruses in tissue cultures of monkey testes. II. Direct isolation and typing of strains from human stools and spinal cords in roller tubes. Am J Hyg. 1952 May;55(3):339–346. doi: 10.1093/oxfordjournals.aje.a119525. [DOI] [PubMed] [Google Scholar]
  18. SABIN A. B. Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. Am J Med Sci. 1955 Jul;230(1):1–8. doi: 10.1097/00000441-195507000-00001. [DOI] [PubMed] [Google Scholar]
  19. SABIN A. B. Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus. Ann N Y Acad Sci. 1955 Sep 27;61(4):924-38; discussion, 938-9. doi: 10.1111/j.1749-6632.1955.tb42551.x. [DOI] [PubMed] [Google Scholar]
  20. SABIN A. B., HENNESSEN W. A., WINSSER J. Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types. J Exp Med. 1954 Jun 1;99(6):551–576. doi: 10.1084/jem.99.6.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SABIN A. B. Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. Ann N Y Acad Sci. 1955 Sep 27;61(4):1050–1056. doi: 10.1111/j.1749-6632.1955.tb42565.x. [DOI] [PubMed] [Google Scholar]
  22. SABIN A. B. Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc. 1956 Dec 29;162(18):1589–1596. doi: 10.1001/jama.1956.02970350005002. [DOI] [PubMed] [Google Scholar]
  23. SALK J. E. Present status of the problem of vaccination against poliomyelitis. Am J Public Health Nations Health. 1955 Mar;45(3):285–297. doi: 10.2105/ajph.45.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES